Saturation mutagenesis of twenty disease-associated regulatory elements at single base-pair resolution

Abstract

The majority of common variants associated with common diseases, as well as an unknown proportion of causal mutations for rare diseases, fall in noncoding regions of the genome. Although catalogs of noncoding regulatory elements are steadily improving, we have a limited understanding of the functional effects of mutations within them. Here, we perform saturation mutagenesis in conjunction with massively parallel reporter assays on 20 disease-associated gene promoters and enhancers, generating functional measurements for over 30,000 single nucleotide substitutions and deletions. We find that the density of putative transcription factor binding sites varies widely between regulatory elements, as does the extent to which evolutionary conservation or integrative scores predict functional effects. These data provide a powerful resource for interpreting the pathogenicity of clinically observed mutations in these disease-associated regulatory elements, and comprise a rich dataset for the further development of algorithms that aim to predict the regulatory effects of noncoding mutations.

Neonatal diabetes mutations disrupt a chromatin pioneering function that activates the human insulin gene

“…These results revealed cis and trans regulators of a previously unrecognized mechanism that activates the endogenous INS gene. Transcriptional regulatory DNA variants play a central role in human disease 44 , yet so far most efforts have investigated their function in experimental systems that do not consider their in vivo impact [45][46][47] . This is a major limitation, because it is currently clear that gene regulation entails a complex interplay between elements that are difficult to reproduce outside of an in vivo context, including chromatin structure, epigenetic chemical modifications, or noncoding RNAs.…”

Deciphering the regulatory logic of aDrosophilaenhancer through systematic sequence mutagenesis and quantitative image analysis

“…Yet, the overall transcriptional levels of developmental genes must be tightly controlled for normal development, as gain-of-function and hypomorph mutants, or RNA-seq experiments show. A number of studies have taken activity levels into account in individual cells in cell culture experiments (e.g., (King et al, 2020;Kircher et al, 2019;Kwasnieski et al, 2012)) or dissociated tissue (e. g., (Farley et al, 2015)), but in this case the information on spatio-temporal variation (the pattern), is lost. By contrast, other studies have quantified pattern elements of enhancer activity but with limited spatial resolution (Crocker et al, 2015;Dufourt et al, 2018)).…”

Prioritization of enhancer mutations by combining allele-specific chromatin accessibility with deep learning

“…We validated this model against melanoma ATAC-seq data from other species, as well as through functional enhancer-reporter assays. We have shown that DeepMEL outperforms other models in a benchmark study using saturation mutagenesis of the IRF4 enhancer, measured by a massively parallel enhancer reporter assay 26 . DeepMEL is able to accurately predict the impact of enhancer mutations in the IRF4 enhancer, and between species.…”